Search clinical trials for: Anastrozole (Arimidex®)
Total 13999 results
-
Hoffmann-La RocheGenentech, Inc.CompletedBreast CancerItaly, Spain, Sweden, China, Hong Kong, Canada, South Africa, Ukraine, United States, United Kingdom, Russian Federation, Taiwan, Australia, Mexico, Turkey, Israel, Poland, Bulgaria, Germany, France, Netherlands, Norway, India, Hungary, Brazi... and more
-
The Affiliated Hospital of Qingdao UniversityUnknown
-
Inge Marie SvaneWithdrawn
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | HER2-negative Breast Cancer | Invasive Lobular Breast Carcinoma | Invasive Ductal Breast CarcinomaUnited States, Puerto Rico
-
Baylor College of MedicineCompletedHypogonadism | Severe ObesityUnited States
-
University of Kansas Medical CenterAstraZenecaCompletedInvasive Breast CancerUnited States
-
AstraZenecaCompleted
-
Stanford UniversityAstraZenecaCompletedBreast CancerUnited States
-
The Affiliated Hospital of Qingdao UniversityUnknownBioequivalence of Oral Formulations of Anastrozole in Healthy Chinese Volunteers Under Fed ConditionHealthy VolunteersChina
-
AstraZenecaCompleted
-
Massachusetts General HospitalTerminatedKallmann Syndrome | Hypogonadotropic HypogonadismUnited States
-
Massachusetts General HospitalNational Institute on Aging (NIA)Completed
-
University of Michigan Rogel Cancer CenterTerminatedBreast CancerUnited States
-
Queen Mary University of LondonCompletedBreast CancerIreland, United Kingdom, Switzerland, Australia, Belgium, Chile, Denmark, Finland, Germany, Hungary, Italy, Malta, Portugal, Turkey
-
AstraZenecaCompleted
-
AstraZenecaCompletedBioequivalence Study Comparing Arimidex Tablet and Anastrozole ODF in Japanese Healthy Male SubjectsPharmacokinetics | SafetyJapan
-
Mayo ClinicNational Cancer Institute (NCI)CompletedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States
-
SanofiActive, not recruitingBreast Cancer MetastaticKorea, Republic of, Belgium, Taiwan, China, France, United States, Argentina, Australia, Brazil, Canada, Czechia, Greece, Israel, Italy, Japan, Latvia, Mexico, Poland, Puerto Rico, Russian Federation, Spain, Turkey, Ukraine
-
AstraZenecaTerminatedNeoplasms | Breast Cancer | Breast NeoplasmsBrazil, Czech Republic, Korea, Republic of, Mexico, Peru, Poland, Russian Federation, South Africa, United Kingdom, Philippines, Ukraine, Finland, Canada, Taiwan, India, Thailand, United States, Japan
-
Kyowa Hakko Kirin Pharma, Inc.CompletedPeripheral T-Cell LymphomaFrance, United Kingdom, Netherlands, Denmark, Italy, Spain
-
Beth Israel Deaconess Medical CenterAstraZenecaCompletedErectile Dysfunction | Hypogonadism | Seizure DisorderUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Dr. Reddy's Laboratories LimitedCompleted
-
Jonsson Comprehensive Cancer CenterEli Lilly and CompanyRecruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Endometrial CarcinomaUnited States
-
Wake Forest University Health SciencesPfizer; Atrium Health Levine Cancer InstituteActive, not recruitingBreast Cancer | Female Breast CarcinomaUnited States
-
Nemours Children's ClinicEMD Serono; AstraZeneca; Genentech, Inc.Completed
-
Trans Tasman Radiation Oncology GroupActive, not recruitingBreast CancerAustralia, New Zealand
-
AstraZenecaCompletedBreast CancerUnited States, Brazil, Czech Republic, France, Hungary, Japan, Belgium, Canada, Netherlands, Italy
-
Borstkanker Onderzoek GroepActive, not recruitingBreast Neoplasm FemaleNetherlands
-
Dr. Reddy's Laboratories LimitedCompleted
-
Massachusetts General HospitalDana-Farber Cancer Institute; Brigham and Women's HospitalCompletedOvarian Cancer | Peritoneal Carcinoma | Tubal CarcinomaUnited States
-
University of ArizonaNational Cancer Institute (NCI); GlaxoSmithKlineTerminatedMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastUnited States
-
AstraZenecaCompletedMetastatic Breast CancerItaly, United Kingdom, Brazil, Czechia, Poland, United States, Spain, Bulgaria, France
-
University of PennsylvaniaCompletedPulmonary Arterial HypertensionUnited States
-
AstraZenecaActive, not recruitingHormone Receptor Positive Breast CancerCanada, Spain, United States, Romania, Taiwan, Italy, Brazil, Peru, Russian Federation, China, Czechia, Ukraine, South Africa, Japan, Poland, Mexico, United Kingdom, Argentina, Slovakia, Turkey
-
Fudan UniversityAstraZenecaUnknown
-
Washington University School of MedicinePfizerActive, not recruitingBreast NeoplasmsUnited States
-
University of Maryland, BaltimoreGenentech, Inc.TerminatedMetastatic Breast CancerUnited States
-
Finn, Olivera, PhDBreast Cancer Research Foundation; A Glimmer of Hope FoundationRecruitingDuctal Carcinoma in SituUnited States
-
Massachusetts General HospitalNational Institutes of Health (NIH); American Diabetes AssociationTerminatedMetabolic SyndromeUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Active, not recruitingStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-positive Breast Cancer | Musculoskeletal ComplicationsUnited States
-
AstraZenecaCompletedProgression-free SurvivalKorea, Republic of
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedBreast CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Invasive Breast Carcinoma | Estrogen Receptor Positive | Stage IV Breast Cancer AJCC v6 and v7United States
-
Thomas Jefferson UniversityContext Therapeutics Inc.Active, not recruitingRefractory Endometrial Carcinoma | Refractory Endometrial Endometrioid Adenocarcinoma | Refractory Endometrial Adenocarcinoma | Refractory Endometrial Clear Cell Adenocarcinoma | Refractory Endometrial Mixed Cell Adenocarcinoma | Refractory Endometrial Serous Adenocarcinoma | Refractory Endometrial...United States